TRVI
USDTrevi Therapeutics Inc. Common Stock
$10.860+0.410 (3.923%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$10.450
High
$10.980
Low
$10.450
Volume
2.49M
Company Fundamentals
Market Cap
1.3B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
2.13M
Exchange
NGM
Currency
USD
52-Week Range
Low $2.36Current $10.860High $11.83
Related News
PR Newswire
Trevi Therapeutics to Participate in Stifel 2025 Healthcare Conference
Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine...
View more
Related Stocks
PAVS
Paranovus Entertainment Technology Ltd. Ordinary Shares
NASDAQ
Medicinal Chemi...
ESTA
Establishment Labs Holdings Inc. Common Shares
NASDAQ
Industrial Spec...
GROW
U.S. Global Investors Inc.
NASDAQ
Investment Mana...
MOND
Mondee Holdings Inc.
NASDAQ
Transportation ...
FRT
Federal Realty Investment Trust
NASDAQ
Real Estate Inv...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.